COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDINE) AND AN ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA

Liquid formulation comprising a) an alpha2 adrenoreceptor agonist eg. clonidine, brimonidine, monoxidine, lofexidine; b) oxybutynin; and c) excipients. The liquid formulation is useful for the treatment of siaiorrhoea.

Saved in:
Bibliographic Details
Main Authors PAUL GOLDSMITH, ALAN GEOFFREY ROACH
Format Patent
LanguageEnglish
Portuguese
Published 30.01.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Liquid formulation comprising a) an alpha2 adrenoreceptor agonist eg. clonidine, brimonidine, monoxidine, lofexidine; b) oxybutynin; and c) excipients. The liquid formulation is useful for the treatment of siaiorrhoea.
Bibliography:Application Number: PT20070705370T